RELEASE OF IRON FROM FERRITIN BY PYRIDOXAL ISONICOTINOYL HYDRAZONE AND RELATED-COMPOUNDS

被引：22

作者：

VITOLO, ML

WEBB, J

SALTMAN, P

机构：

[1] MURDOCH UNIV,SCH MATH & PHYS SCI,MURDOCH,WA 6150,AUSTRALIA

[2] UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093

来源：

JOURNAL OF INORGANIC BIOCHEMISTRY | 1984年 / 20卷 / 03期

关键词：

D O I：

10.1016/0162-0134(84)85023-0

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：255 / 262

页数：8

共 50 条

[31] Orally effective iron chelators for the treatment of iron overload disease: The case for a further look at pyridoxal isonicotinoyl hydrazone and its analogs
Richardson, DR
Ponka, P
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 132 (04): : 351 - 352
[32] Pyridoxal isonicotinoyl hydrazone and its analogs: Potential orally effective iron-chelating agents for the treatment of iron overload disease
Richardson, DR
Ponka, P
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1998, 131 (04): : 306 - 315
[33] Mobilization of intracellular iron by analogs of pyridoxal. isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes
Buss, JL
Arduini, E
Ponka, P
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (12) : 1689 - 1701
[34] IRON CHELATORS OF THE PYRIDOXAL ISONICOTINOYL HYDRAZONE CLASS .1. IONIZATION CHARACTERISTICS OF THE LIGANDS AND THEIR RELEVANCE TO BIOLOGICAL PROPERTIES
RICHARDSON, DR
VITOLO, LMW
HEFTER, GT
MAY, PM
CLARE, BW
WEBB, J
WILAIRAT, P
INORGANICA CHIMICA ACTA, 1990, 170 (02) : 165 - 170
[35] STUDY OF INTRACELLULAR IRON-METABOLISM USING PYRIDOXAL ISONICOTINOYL HYDRAZONE AND OTHER SYNTHETIC CHELATING-AGENTS
PONKA, P
BOROVA, J
NEUWIRT, J
FUCHS, O
NECAS, E
BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 586 (02) : 278 - 297
[36] Iron chelators of the class of pyridoxal acylhydrazone. Part 5. Crystal structure and patterns of hydrogen bonding in Pyridoxal Isonicotinoyl Hydrazone (PIH)
Sarel, S
Cohen, S
Avramovici-Grisaru, S
HETEROCYCLES, 1998, 47 (02) : 1033 - 1042
[37] PREDOMINANCE OF BILIARY IRON CHELATES IN IRON-LOADED RATS INVIVO DURING IV DEFEROXAMINE (DF) OR PYRIDOXAL ISONICOTINOYL HYDRAZONE (PIH)
SHARMA, BK
TAVILL, AS
LOUIS, LN
VARNES, AW
HEPATOLOGY, 1988, 8 (05) : 1240 - 1240
[38] Iron chelation from murine reticulocytes: Structure-activity relationships among halogenated analogs of pyridoxal isonicotinoyl hydrazone and effects of albumin of iron efflux.
Arduini, E
Buss, JL
Ponka, P
BLOOD, 1998, 92 (10) : 11B - 11B
[39] Lipophilicity of analogs of pyridoxal isonicotinoyl hydrazone (PTH) determines the efflux of iron complexes and toxicity in K562 cells
Buss, JL
Arduini, E
Shephard, KC
Ponka, P
BIOCHEMICAL PHARMACOLOGY, 2003, 65 (03) : 349 - 360
[40] Cytotoxic analogs of the iron(III) chelator pyridoxal isonicotinoyl hydrazone: Effects of complexation with copper(II), gallium(III), and iron(III) on their antiproliferative activities
Richardson, DR
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) : 2061 - 2063

← 1 2 3 4 5 →